Conjugated anionic PEG-citrate G2 dendrimer with multi-epitopic HIV-1 vaccine candidate enhance the cellular immune responses in mice

被引:17
作者
Abdoli, Asghar [1 ,2 ]
Radmehr, Nina
Bolhassani, Azam [1 ]
Eidi, Akram [2 ]
Mehrbod, Parvaneh [3 ]
Motevalli, Fatemeh [1 ]
Kianmehr, Zahra [4 ]
Chiani, Mohsen [5 ]
Mahdavi, Mehdi [6 ]
Yazdani, Shaghayegh [7 ]
Ardestani, Mehdi Shafiee [8 ]
Kandi, Mohammad Reza [9 ]
Aghasadeghi, Mohammad Reza [1 ]
机构
[1] Pasteur Inst Iran, Hepatitis & AIDS Dept, Tehran, Iran
[2] Islamic Azad Univ, Fac Basic Sci, Sci & Res Branch, Tehran, Iran
[3] Pasteur Inst Iran, Influenza & Other Resp Viruses Dept, Tehran, Iran
[4] Shahed Univ, Immunoregulat Res Ctr, Tehran, Iran
[5] Pasteur Inst Iran, Dept Pilot Biotechnol, Tehran, Iran
[6] Pasteur Inst Iran, Dept Immunol, Tehran, Iran
[7] Univ Tehran Med Sci, Sch Publ Hlth, Dept Virol, Tehran, Iran
[8] Univ Tehran Med Sci, Fac Pharm, Dept Radiopharm, Tehran, Iran
[9] Univ Tehran, Fac New Sci & Technol, Dept Life Sci Engn, Tehran, Iran
基金
美国国家科学基金会;
关键词
Epitope; vaccine; HIV; dendrimer; CpG motif; DNA; NANOPARTICLES; PEPTIDE; DRUG; STRATEGY; DELIVERY; ANTIGEN; BINDING; CELLS; GAG;
D O I
10.1080/21691401.2017.1290642
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Multi-epitope vaccines might cause immunity against multiple antigenic targets. Four immunodominant epitopes of HIV-1 genome were used to construct a polytope vaccine, formulated by dendrimer. Two regimens of polytopes mixture with dendrimer were utilized to immunize BALB/c mice. Adjuvants were also used to boost immune responses. The conjugated polytope could arouse significant cellular immune responses (P<0.05) and Th1 response showed higher intensity compared to Th2 (P<0.05). Our study depicted that conjugated dendrimer with multi-epitopic rHIVtop4 would efficiently induce cell-mediated immune responses and might be considered as promising delivery system for vaccines formulation.
引用
收藏
页码:1762 / 1768
页数:7
相关论文
共 35 条
  • [1] An H1-H3 chimeric influenza virosome confers complete protection against lethal challenge with PR8 (H1N1) and X47 (H3N2) viruses in mice
    Abdoli, Asghar
    Soleimanjahi, Hoorieh
    Kheiri, Masoumeh Tavassoti
    Jamali, Abbas
    Mazaheri, Vahideh
    Alitappeh, Meghdad Abdollahpour
    [J]. PATHOGENS AND DISEASE, 2014, 72 (03): : 197 - 207
  • [2] [Anonymous], 2014, VACCINE RES
  • [3] Ardestani MS, 2015, J MATER SCI-MATER M, V26, P1
  • [4] CPG 7909 adjuvant plus hepatitis B virus vaccination in HIV-infected adults achieves long-term seroprotection for up to 5 years
    Cooper, C. L.
    Angel, J. B.
    Seguin, I.
    Davis, H. L.
    Cameron, D. W.
    [J]. CLINICAL INFECTIOUS DISEASES, 2008, 46 (08) : 1310 - 1314
  • [5] CD8+T Cell Control of HIV-A Known Unknown
    Davenport, Miles P.
    Petravic, Janka
    [J]. PLOS PATHOGENS, 2010, 6 (01)
  • [6] Subtype AE HIV-1 DNA and recombinant Fowlpoxvirus vaccines encoding five shared HIV-1 genes: safety and T cell immunogenicity in macaques
    De Rose, R
    Chea, S
    Dale, CJ
    Reece, J
    Fernandez, CS
    Wilson, KM
    Thomson, S
    Ramshaw, IA
    Coupar, BEH
    Boyle, DB
    Sullivan, MT
    Kent, SJ
    [J]. VACCINE, 2005, 23 (16) : 1949 - 1956
  • [7] Dezfuli Hoda Taghizadeh, 2014, Gastroenterol Hepatol Bed Bench, V7, P108
  • [8] Phenotypic, functional, and kinetic parameters associated with a apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment
    Emu, B
    Sinclair, E
    Favre, D
    Moretto, WJ
    Hsue, P
    Hoh, R
    Martin, JN
    Nixon, DF
    McCune, JM
    Deeks, SG
    [J]. JOURNAL OF VIROLOGY, 2005, 79 (22) : 14169 - 14178
  • [9] Nanoparticles in cellular drug delivery
    Faraji, Amir H.
    Wipf, Peter
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (08) : 2950 - 2962
  • [10] Dendrimers for Vaccine and Immunostimulatory Uses. A Review
    Heegaard, Peter M. H.
    Boas, Ulrik
    Sorensen, Nanna Skall
    [J]. BIOCONJUGATE CHEMISTRY, 2010, 21 (03) : 405 - 418